ELISPOT assay: principle, variants, applications and limitations

Basic principle and workflow

In a typical ELISPOT experiment, a membrane-bottomed plate is pre-coated with a capture antibody that binds the target molecule. Viable cells are added and incubated so that secreted proteins are trapped immediately around each secreting cell. After washing away cells and unbound material, a detection antibody linked to an enzyme is applied and a chromogenic substrate is added to produce an insoluble colored precipitate at the capture site. Each precipitate appears as a spot, which corresponds to one secreting cell or a cluster of nearby secreting cells. The main steps are often summarized as:

• Plate coating with capture antibody
• Cell incubation and stimulation (if required)
• Washing and application of detection antibody
• Enzymatic development and spot formation
• Spot counting (manual or automated)

Variants and technical details

ELISPOT plates commonly use nitrocellulose or PVDF membranes to retain bound proteins. Variations include assays specialized for interferon-gamma (IFN-γ ELISPOT), B-cell/antibody ELISPOT for measuring antibody-secreting cells, and multiplexed FluoroSpot assays that use fluorescent labels to detect multiple analytes from the same cell. Automation and image-analysis software can quantify spot number, size and intensity; many labs reference instrument guides or protocols available at cytokine resources and antibody assay collections.

Applications and importance

ELISPOT is widely used in immunomonitoring because of its sensitivity and low cell requirement. Common applications include evaluating T-cell responses after vaccination, measuring B-cell responses or antibody-secreting cells in infection and vaccination studies, and assessing immune responses in clinical trials of immunotherapies. Its single-cell sensitivity allows detection of rare antigen-specific cells that might be missed by bulk assays. For practical examples involving peripheral blood mononuclear cells (PBMCs) see blood cell assay resources.

Advantages and limitations

Advantages of ELISPOT include high sensitivity (ability to detect single secreting cells), quantitative spot counts, and relative simplicity compared with some cell-based assays. Limitations include the loss of phenotypic information unless combined with parallel assays, dependence on viable cells and appropriate stimulation protocols, and potential ambiguity in interpreting large or merged spots. FluoroSpot and combining ELISPOT with cell-sorting or flow-cytometry techniques can help address some limitations.

Historical note and practical considerations

ELISPOT emerged in the early 1980s as a practical adaptation of immunoassay principles to single-cell analysis. Since then it has evolved with improved membranes, reagents and image-analysis tools. When designing or interpreting an ELISPOT study, key considerations are the choice of capture/detection antibodies, cell number per well, stimulation conditions, appropriate controls, and the method used for spot counting. Proper controls and standardized protocols are essential for reproducible results and meaningful comparisons across studies.

See also: assay variants such as IFN-γ ELISPOT, B-cell ELISPOT and FluoroSpot, and comparative methods like ELISA and intracellular cytokine staining for broader immunological assessment.